New York City, NY – According to filings with the U.S. Securities and Exchange Commission, Capital Rx is raising $52,999,994.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Aj Loiacono played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Capital Rx

Capital Rx is redefining the way prescriptions are priced and administered in the U.S. Through its Clearinghouse Model, Capital Rx unlocks the pharmacy supply chain and reduces prescription costs for employer groups. By establishing a competitive marketplace for drug pricing, Capital Rx focuses its resources on deploying actionable strategies that improve plan performance and patient outcomes. The company’s commitment to innovation, technology, and service is why Capital Rx is the fastest-growing pharmacy benefit manager in America.

To learn more about Capital Rx, visit http://cap-rx.com/

Contact:
Aj Loiacono, Chief Executive Officer
855-538-8897
https://www.linkedin.com/in/capitalrx/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved